Reporting and interpretation of results from clinical trials that did not claim a treatment difference: survey of four general medical journals

被引:25
|
作者
Gates, Simon [1 ]
Ealing, Elizabeth [2 ]
机构
[1] Univ Birmingham, Canc Res UK Clin Trials Unit, Birmingham, W Midlands, England
[2] Univ Warwick, Warwick Clin Trials Unit, Coventry, W Midlands, England
来源
BMJ OPEN | 2019年 / 9卷 / 09期
关键词
clinical trials; reporting; statistics & research methods; CONFIDENCE-INTERVALS; P-VALUES; MISINTERPRETATION; STATISTICS;
D O I
10.1136/bmjopen-2018-024785
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objectives To describe and summarise how the results of randomised controlled trials (RCTs) that did not find a significant treatment effect are reported, and to estimate how commonly trial reports make unwarranted claims. Design We performed a retrospective survey of published RCTs, published in four high impact factor general medical journals between June 2016 and June 2017. Setting Trials conducted in all settings were included. Participants 94 reports of RCTs that did not find a difference in their main comparison or comparisons were included. Interventions All interventions. Primary and secondary outcomes We recorded the way the results of each trial for its primary outcome or outcomes were described in Results and Conclusions sections of the Abstract, using a 10-category classification. Other outcomes were whether confidence intervals (CIs) and p values were presented for the main treatment comparisons, and whether the results and conclusions referred to measures of uncertainty. We estimated the proportion of papers that made claims that were not justified by the results, or were open to multiple interpretations. Results 94 trial reports (120 treatment comparisons) were included. In Results sections, for 58/120 comparisons (48.3%) the results of the study were re-stated, without interpretation, and 38/120 (31.7%) stated that there was no statistically significant difference. In Conclusions, 65/120 treatment comparisons (54.2%) stated that there was no treatment benefit, 14/120 (11.7%) that there was no significant benefit and 16/120 (13.3%) that there was no significant difference. CIs and p values were both presented by 84% of studies (79/94), but only 3/94 studies referred to uncertainty when drawing conclusions. Conclusions The majority of trials (54.2%) inappropriately interpreted a result that was not statistically significant as indicating no treatment benefit. Very few studies interpreted the result as indicating a lack of evidence against the null hypothesis of zero difference between the trial arms.
引用
收藏
页数:7
相关论文
共 26 条
  • [21] Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: Results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study
    Gridelli, Cesare
    Ardizzoni, Andrea
    Barni, Sandro
    Crino, Lucio
    Caprioli, Alberto
    Piazza, Elena
    Lorusso, Vito
    Barbera, Santi
    Zilembo, Nicoletta
    Gebbia, Vittorio
    Adamo, Vincenzo
    Pela, Riccardo
    Marangolo, Maurizio
    Morena, Raffaella
    Filippelli, Gianfranco
    Buscarino, Calogero
    Alabiso, Oscar
    Maione, Paolo
    Venturino, Paola
    De Marinis, Filippo
    LUNG CANCER, 2011, 74 (03) : 462 - 468
  • [22] Characteristics of Ryan White and non-Ryan White funded HIV medical care facilities across four metropolitan areas: results from the Antiretroviral Treatment and Access Studies site survey
    Valverde, E
    Del Rio, C
    Metsch, L
    Anderson-Mahoney, P
    Krawczyk, CS
    Gooden, L
    Gardner, LI
    AIDS CARE-PSYCHOLOGICAL AND SOCIO-MEDICAL ASPECTS OF AIDS/HIV, 2004, 16 (07): : 841 - 850
  • [23] How is oral isotretinoin prescribed for the treatment of acne vulgaris? Results from a UK Dermatology Clinical Trials Network (UKDCTN) and British Dermatological Nursing Group (BDNG) survey of health professionals
    Moledina, Zahra
    McPhee, Margaret
    Ravenscroft, Jane C.
    Healy, Eugene
    Radley, Kathy
    Thomas, Kim S.
    Burden-Teh, Esther
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2023, 48 (01) : 20 - 23
  • [24] Epidemiology and clinical spectrum of polymyositis and dermatomyositis in France: Results of a nationwide survey. The EDT (epidemiologic-diagnostic treatment) French myostis study from 405 medical departments
    Cherin, P
    Pagnoux, C
    Bonnelye, G
    Touboul, C
    NEUROLOGY, 2006, 66 (05) : A151 - A151
  • [25] Evaluation of acute migraine attack treatment in general population:: the set of four questions from French Guidelines.: Results of FRAMIG3, a French population-based survey carried out according the 2004 IHS Classification
    Lucas, C
    Lantéri-Minet, M
    Chautard, MH
    CEPHALALGIA, 2005, 25 (10) : 922 - 922
  • [26] Medical treatment choices of over 1000 Italian patients affected by stage IIIB-IV NSCLC in routine clinical practice: results from the observational "SUN" (Survey on the lUng cancer maNagement) study on behalf of SUN study Group
    Barni, S.
    Bajetta, E.
    De Marinis, F.
    Crino, L.
    Ardizzoni, A.
    Caprioli, A.
    Favaretto, A.
    Giannicola, R.
    Filippelli, G.
    Gridelli, C.
    EJC SUPPLEMENTS, 2009, 7 (02): : 515 - 516